American International Group, Inc. Protagonist Therapeutics, Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$21.79 - $32.15 $5,251 - $7,748	-241 Reduced 0.85%	28,149 $814,000
Q4 2023 Feb 13, 2024	SELL	$14.05 - $23.44 $1,615 - $2,695	-115 Reduced 0.4%	28,390 $650,000
Q3 2023 Nov 13, 2023	BUY	$16.68 - $23.66 $40,215 - $57,044	2,411 Added 9.24%	28,505 $475,000
Q2 2023 Aug 04, 2023	BUY	$18.02 - $29.36 $65,556 - $106,811	3,638 Added 16.2%	26,094 $720,000
Q1 2023 May 12, 2023	BUY	$10.78 - $25.38 $4,818 - $11,344	447 Added 2.03%	22,456 $516,000
Q4 2022 Feb 10, 2023	BUY	$7.36 - $11.17 $1,207 - $1,831	164 Added 0.75%	22,009 $240,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $2,420 - $3,606	308 Added 1.43%	21,845 $184,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $25.52 $4,751 - $17,174	-673 Reduced 3.03%	21,537 $170,000
Q1 2022 May 13, 2022	SELL	$23.34 - $36.08 $36,457 - $56,356	-1,562 Reduced 6.57%	22,210 $526,000
Q4 2021 Feb 11, 2022	SELL	$17.63 - $37.1 $12,534 - $26,378	-711 Reduced 2.9%	23,772 $813,000
Q3 2021 Nov 12, 2021	BUY	$12.95 - $49.69 $17,068 - $65,491	1,318 Added 5.69%	24,483 $434,000
Q2 2021 Aug 13, 2021	BUY	$25.57 - $44.88 $67,453 - $118,393	2,638 Added 12.85%	23,165 $1.04 Million
Q1 2021 May 07, 2021	BUY	$19.02 - $31.15 $42,300 - $69,277	2,224 Added 12.15%	20,527 $532,000
Q4 2020 Feb 12, 2021	BUY	$18.49 - $25.13 $3,476 - $4,724	188 Added 1.04%	18,303 $369,000
Q3 2020 Nov 04, 2020	BUY	$15.19 - $22.4 $65,408 - $96,454	4,306 Added 31.18%	18,115 $354,000
Q2 2020 Aug 12, 2020	BUY	$6.19 - $18.84 $20,860 - $63,490	3,370 Added 32.28%	13,809 $244,000
Q1 2020 May 04, 2020	SELL	$5.4 - $9.22 $3,250 - $5,550	-602 Reduced 5.45%	10,439 $74,000
Q4 2019 Feb 05, 2020	BUY	$4.69 - $13.45 $1,341 - $3,846	286 Added 2.66%	11,041 $78,000
Q3 2019 Nov 08, 2019	BUY	$9.41 - $16.56 $10,473 - $18,431	1,113 Added 11.54%	10,755 $129,000
Q2 2019 Aug 13, 2019	BUY	$8.98 - $12.96 $86,585 - $124,960	9,642 New	9,642 $117,000
Q2 2018 Aug 08, 2018	SELL	$5.99 - $9.1 $43,637 - $66,293	-7,285 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$8.46 - $23.08 $3,316 - $9,047	-392 Reduced 5.11%	7,285 $63,000
Q4 2017 Feb 09, 2018	BUY	$14.47 - $20.8 $20,098 - $28,891	1,389 Added 22.09%	7,677 $160,000
Q3 2017 Nov 09, 2017	BUY	$10.61 - $17.98 $66,715 - $113,058	6,288	6,288 $111,000

Others Institutions Holding PTGX

# of Institutions

248

Shares Held

56.7M

Call Options Held

76.3K

Put Options Held

114K

Farallon Capital Management LLC San Francisco, CA

5.86M
Shares

$230 Million
1.32% of portfolio
Black Rock Inc. New York, NY

5.76M
Shares

$226 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$213 Million
3.89% of portfolio
Vanguard Group Inc Valley Forge, PA

4.22M
Shares

$166 Million
0.0% of portfolio
State Street Corp Boston, MA

3.18M
Shares

$125 Million
0.01% of portfolio

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account